Phillip Broadwith's profile photo

Phillip Broadwith

Cambridge

Business Editor for @chemistryworld, when I'm not dancing, cricketing or at the allotment. All opinions my own.

Articles

  • 1 week ago | chemistryworld.com | Phillip Broadwith

    Can plants adapt to be compatible with a lower-carbon environment? Once Petroineos’s Grangemouth refinery closes this year, the UK will have five working oil refineries, down from a peak of 18 in the 1970s. As demand for fossil-derived fuels declines, and competition from abroad intensifies, that number seems set to fall further. The surviving plants will likely be those that are already moving toward cleaner, more efficient, and more sustainable operation.

  • 3 weeks ago | chemistryworld.com | Phillip Broadwith

    Blueprint has one approved drug and enhances Sanofi’s immunology portfolio Source: © HJBC/Shutterstock As part of a strategy to strengthen its immunology segment through acquisitions, Sanofi has agreed to buy US-based Blueprint Medicines in a deal worth $9.1 billion (£6.7 billion) in cash, with an additional $400 million on offer in performance milestone payments.

  • 1 month ago | chemistryworld.com | Phillip Broadwith

    Six others missing and 19 injured at Shandong Youdao Chemical Source: © Liang Ben/China News Service/VCG/Getty Images Five people have died and six others are missing after an explosion and fire at a chemical plant in Gaomi, China on 27 May. The incident at Shandong Youdao Chemical injured 19 other people, according to reports in the South China Morning Post. The cause of the incident is yet to be determined.

  • 1 month ago | chemistryworld.com | Phillip Broadwith

    Developing therapies for conditions that predominantly affect women is an neglected, but enormous, opportunity Source: © SolStock/Getty Images Pharmaceutical and medical science has a massive knowledge gap around women’s health. As outlined in a special collection of Chemistry World articles, conditions that only affect women, or affect them very differently to men, have been systematically ignored or dismissed for most of medical history.

  • 1 month ago | chemistryworld.com | Phillip Broadwith

    Multinationals are promising huge US investments, but it’s not all because of Trump’s policies Source: © Extreme Media/Getty Images Donald Trump says he wants more of the medicines US patients use to be manufactured within the US. And to make that happen, he’s brandishing both stick and carrot.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
604
Tweets
1K
DMs Open
No
Phillip Broadwith
Phillip Broadwith @broadwithp
26 Feb 25

RT @NakedScientists: What is mirror life? This episode features @broadwithp @ChemistryWorld on chirality; Jonathan Jarry @McGillOSS on mir…

Phillip Broadwith
Phillip Broadwith @broadwithp
6 Jan 25

RT @BWeckhuysen: Reflecting on Two Decades of Change in Research I became a @RoySocChem member in 2004, when Chemistry World was first lau…

Phillip Broadwith
Phillip Broadwith @broadwithp
1 Aug 24

RT @tuckerian: ATTENTION SCIENCE AND TECHNOLOGY JOURNALISTS! Are you interested in writing for the Observer? I am looking for new writers a…